NDC 50242-210 – Gavreto
Pralsetinib 100 mg/1 · Capsule · Oral
Product NDC50242-210
Product details
- Brand name
- Gavreto
- Generic name
- Pralsetinib
- Labeler
- Genentech, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA213721
- Marketed since
- July 1, 2021
- Marketing end
- September 30, 2026
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Pralsetinib 100 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 50242-210-60 | 1 BOTTLE in 1 CARTON (50242-210-60) / 60 CAPSULE in 1 BOTTLE | Jul 1, 2021 |
| 50242-210-83 sample | 1 BOTTLE in 1 CARTON (50242-210-83) / 60 CAPSULE in 1 BOTTLE | Jul 1, 2021 |
| 50242-210-90 | 1 BOTTLE in 1 CARTON (50242-210-90) / 90 CAPSULE in 1 BOTTLE | Jul 1, 2021 |
Other Gavreto products
- 71332-006 Pralsetinib 100 mg/1 · Capsule · Rigel Pharmaceuticals, Inc.